Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases / Five Star Equities Provides Stock Research on Complete Genomics and Exelixis
08:22 EST 22 Nov 2012 | FinanzNachrichten
NEW YORK, NY -- (Marketwire) -- 11/22/12 -- The Biotech Industry has skyrocketed in 2012 as an increase in the number of new drug approvals has boosted investor optimism within the industry. The iS...
Original Article: Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases / Five Star Equities Provides Stock Research on Complete Genomics and Exelixis
More From BioPortfolio on "Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases / Five Star Equities Provides Stock Research on Complete Genomics and Exelixis"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
